Drug intelligence / Profile preview

ZymaDerm

Development stage
Unknown
Lead developer
Naturopathix
Modality
Small Molecules
Administration
Topical
01

Overview

**ZymaDerm** is a branded homeopathic topical liquid developed and marketed by Naturopathix for the treatment of **molluscum contagiosum**. It is a **multi-ingredient combination product** containing homeopathic active ingredients including **argentum nitricum**, **echinacea angustifolia**, **fucus vesiculosus**, and **thuja occidentalis**, with additional non-homeopathic excipients such as tea tree oil, Backhousia citriodora oil, clove oil, selenium-rich canola oil, and fractionated coconut oil. It is applied directly to skin lesions twice daily and is marketed primarily for pediatric and adult patients with molluscum contagiosum. The product is positioned as a homeopathic medicine rather than an evidence-based targeted pharmaceutical, and a precise molecular mechanism of action for its clinical effect has not been established.

Brand names
ZymaDerm

Beyond the preview

Go deeper on ZymaDerm.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZymaDerm.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call